For example, coupling the self-renewal potential of TN/SCM with the typical effector capabilities of CD28 and its lower sensitivity to antigen density compared with 4-1BB (52) could provide the right balance to increase long-term persistence, without threatening efficient and rapid tumor debulking when dealing with solid malignancies or tumors expressing low antigen levels. The gene discussed is CD28; the disease is neoplasm.